Current Price
Target Price
Synthorx, Inc., a biopharmaceutical company, is focused on developing Synthorin cytokine programs for the treatment of cancer and autoimmune disorders in the United States. The company is headquartered in La Jolla, Calif...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | TTri-Contin... | TY-P | $2.47B | — | — | — | — | — | — |
| 2. | BBrighthous... | BHFAL | $3.44B | — | — | — | — | — | — |
| 3. | RReady Capi... | RCC | $1.74B | — | — | — | — | 14.30% | — |
| 4. | SStifel Fin... | SFB | $6.99B | — | — | — | — | 19.60% | — |
| 5. | WWestar Ene... | WR | $7.68B | 23.79 | — | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Dec 17 | Mar 18 | Jun 18 | Sep 18 | Dec 18 | Mar 19 | Jun 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COGS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 4.34 | 2.19 | 3.09 | 5.93 | 8.79 | 11.92 | 13.46 | 13.18 | |
EBIT | -4.34 | -2.19 | -3.09 | -5.93 | -8.79 | -11.92 | -13.46 | -13.18 |
OPM % | - | - | - | - | - | - | - | - |
Non-Operating Income | 0 | 0 | -0.01 | -16.32 | -19.37 | 1.07 | 1.09 | 0.96 |
PBT | -4.34 | -2.19 | -3.1 | -22.25 | -28.16 | -10.85 | -12.37 | -12.22 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | 0% | 0% | 0% | 0% | 0% | - | - | - |
Net Income | -4.34 | -2.19 | -3.1 | -22.25 | -28.16 | -10.85 | -12.37 | -12.22 |
NPM % | - | - | - | - | - | - | - | - |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2016 | Dec 2017 | Dec 2018 |
|---|---|---|---|---|---|---|
Revenue | 422.71 | 491.65 | 502.82 | 0 | 0 | 0 |
COGS | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 287.65 | 291.38 | 339.27 | 0 | 0 | 0 |
Gross Profit % | 68.05% | 59.26% | 67.47% | - | - | - |
| 173.49 | 215.71 | 241.72 | 3.13 | 5.85 | 20.9 | |
EBIT | 114.16 | 75.66 | 97.55 | -3.13 | -5.85 | -20.9 |
OPM % | 27.01% | 15.39% | 19.4% | - | - | - |
Non-Operating Income | -114.16 | -75.66 | -97.55 | 0 | 0 | -35.71 |
PBT | 0 | 0 | 0 | -3.13 | -5.85 | -56.61 |
Income Tax | 39.3 | 21.15 | 26.43 | 0 | 0 | 0 |
Tax Rate % | - | - | - | 0% | 0% | 0% |
Net Income | 71.54 | 56.16 | 73.33 | -3.13 | -5.85 | -56.61 |
NPM % | 16.92% | 11.42% | 14.58% | - | - | - |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2016 | Dec 2017 | Dec 2018 |
|---|---|---|---|
| 4.13 | 3.66 | 188.36 | |
| 0 | 0 | 0 | |
| 0.43 | 0.69 | 1.38 | |
| 0.01 | 0.03 | 0 | |
| 0 | 0.09 | 1.77 | |
Total Assets | 4.58 | 4.47 | 191.51 |
| 0 | 0 | 0.03 | |
| -6.76 | -12.53 | 184.33 | |
| 0 | 0 | 0 | |
| 0.23 | 0.88 | 3.37 | |
| 11.11 | 16.12 | 3.77 | |
Total Liabilities | 4.58 | 4.47 | 191.51 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2016 | Dec 2017 | Dec 2018 |
|---|---|---|---|---|---|---|
| 110.71 | 139.54 | 109.77 | -2.77 | -5.08 | -16.48 | |
| 126.27 | -11.04 | -37.88 | -0.4 | -0.39 | -0.92 | |
| -252.05 | -70.19 | -34.59 | 4.88 | 5 | 202.09 | |
Net CFNet Cash Flow | -15.07 | 58.3 | 37.3 | 1.71 | -0.47 | 184.69 |
FCFFree Cash Flow | 104.5 | 128.82 | 101.07 | -3.17 | -5.47 | -17.4 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2016 | Dec 2017 | Dec 2018 |
|---|---|---|---|
| - | 60.7% | -65.9% | |
| - | - | - | |
| 18.02 | 4.23 | 26.99 | |
| - | 0.00 | 0.00 | |
Cash Conversion | 0.88 | 0.87 | 0.29 |
Payout Ratio | - | - | - |
| -100.0% | - | - | |
| - | - | - | |
| - | - | - | |
| 3.00 | 3.00 | 4.00 | |
| - | - | - | |
| - | - | 0.00 | |
| - | - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns THORNBURG PREMIUM INCOME BUILDER ETF, from SEC filings
Who owns the company, quarter by quarter
Calendar quarters (13F report dates). Jun 2026 can still change as late 13F amendments arrive.
| Shares held | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2026 | QoQ |
|---|---|---|---|---|---|---|---|---|---|
InsidersInsiders | 13.6M | 13.6M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 0 | -2.1M |
ForeignForeign institutions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.8K | +130.8K | |
Govt.Government & pensions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of institutional holders | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | +2 |
Insiders = officers, directors and 10% owners (Forms 3/4/5). Foreign vs US = the 13F manager's registered address. Government = sovereign funds, central banks and public pensions. Public includes retail investors and funds below the $100M 13F threshold. Named holders are the largest 13F filers each quarter; shares outstanding come from the 10-K / 10-Q cover page.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 13,137 | -10.0% | 1.00 | |
| 15 Oct 2026 | 14,589 | -63.6% | 1.00 | |
| 30 Sep 2026 | 40,070 | -19.0% | 1.43 | |
| 15 Sep 2026 | 49,474 | +265.1% | 1.06 | |
| 31 Aug 2026 | 13,549 | -15.8% | 1.00 | |
| 14 Aug 2026 | 16,082 | +1.4% | 1.11 | |
| 31 Jul 2026 | 15,865 | +58.2% | 1.51 | |
| 15 Jul 2026 | 10,030 | +12.5% | 1.18 | |
| 30 Jun 2026 | 8,919 | 1.00 | ||
| 15 Jan 2020 | 287,234 | -23.9% | 1.00 | |
| 31 Dec 2019 | 377,571 | +3.6% | 1.00 | |
| 13 Dec 2019 | 364,494 | -62.4% | 1.00 | |
| 29 Nov 2019 | 969,496 | +15.6% | 9.17 | |
| 15 Nov 2019 | 838,936 | +1.7% | 8.98 | |
| 31 Oct 2019 | 824,912 | +10.5% | 8.57 | |
| 15 Oct 2019 | 746,419 | -16.6% | 7.55 | |
| 30 Sep 2019 | 895,514 | +2.8% | 10.57 | |
| 13 Sep 2019 | 871,004 | -2.1% | 25.83 | |
| 30 Aug 2019 | 889,393 | +6.9% | 16.95 | |
| 15 Aug 2019 | 831,855 | -2.3% | 26.79 | |
| 31 Jul 2019 | 851,780 | -15.2% | 15.32 | |
| 15 Jul 2019 | 1,004,951 | +0.7% | 23.86 | |
| 28 Jun 2019 | 997,872 | -8.8% | 12.29 | |
| 14 Jun 2019 | 1,094,095 | -0.3% | 12.53 |
FINRA consolidated short interest, reported twice a month for every US listing.
THORNBURG PREMIUM INCOME BUILDER ETF's SEC filings and earnings call transcripts
What recent news says about THORNBURG PREMIUM INCOME BUILDER ETF, scored for sentiment.